Identifying quality of life indicators to improve outpatient pharmacy services for prostate cancer patients: a comparison between brazilian and british experiences-Reference-Cited by-同舟云学术

Identifying quality of life indicators to improve outpatient pharmacy services for prostate cancer patients: a comparison between brazilian and british experiences

Published:2019-06 Issue:3 Volume:45 Page:435-448
ISSN:1677-6119
Container-title:International braz j urol
language:
Short-container-title:Int. braz j urol.

Author:

Patel Harindra¹,Aguiar Patrícia Melo²,Pessoa Jr. Adalberto³,Storpirtis Sílvia²,Long Paul F.⁴^ORCID

Affiliation:

1. King's College London, United Kingdom, UK

2. Universidade de São Paulo - USP, Brasil; Farmácia Universitária da Universidade de São Paulo - USP, Brasil

3. Universidade de São Paulo - USP, Brasil

4. King's College London, United Kingdom, UK; Universidade de São Paulo - USP, Brasil

Publisher

FapUNIFESP (SciELO)

Subject

Urology

Link

http://www.scielo.br/pdf/ibju/v45n3/1677-6119-ibju-45-03-0435.pdf

Reference30 articles.

1. Patient survival and risk of death after prostate cancer treatment in the Brazilian Unified Health System;Braga SFM;Rev Saude Publica.,2017

2. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay J;Int J Cancer.,2015

3. Epidemiology of prostate cancer and treatment remarks;Arcangeli S;World J Radiol.,2012

4. 2010 Population Census

5. Is prostate cancer different in black men? Answers from 3 natural history models;Tsodikov A;Cancer.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Outcome Measurement of iFactor/ABM/P-15 in Lumbar Spine Surgery: A Systematic Review;Global Spine Journal;2023-11-23

2. A scoping review to compare and contrast quality assurance aspects of l-asparaginase biosimilars;International Journal of Pharmaceutics;2023-02

3. The multiparametric prostate resonance imaging with the prostate imaging-reporting and data system (PI-RADS): the state of art of prostate cancer diagnosis;International braz j urol;2019-06